Overview Of Polycystic Ovary Syndrome (PCOS)

PCOS, commonly known as hyperandrogenic anovulation, is a condition that affects women's ovaries. A frequent endocrine system illness that affects women of reproductive age is polycystic ovarian syndrome (PCOS), also known as hyperandrogenic anovulation (HA), or Stein-Leventhal syndrome (Evans and Riley, 1958). According to Stein and Leventhal (1935), it is a condition that develops on one or both ovaries when an estimated 10 tiny cysts with a diameter ranging from 2 to 9 mm and/or an ovarian volume greater than 10 ml are present. According to a systematic examination of women using National Institutes of Health (NIH) diagnostic criteria, 4–10% of women of reproductive age have PCOS. Recent research reveals that PCOS is a lifelong syndrome that first manifests during pregnancy, despite the fact that it was traditionally thought to be a disorder that only affected adult women. It is a syndrome that can be avoided by raising awareness among patients and healthcare professionals. Starting with its diagnosis, pathophysiology, repercussions, and treatment options, there are numerous areas of disagreement(1).